Harshita Nivrutti Khedkar (Harshita Khedkar)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Squamous Cell Carcinoma

Radiation Therapy

Cancer Stem Cells

Bioinformatics Analysis

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Harshita Nivrutti Khedkar, Lung-Ching Chen, Yu-Cheng Kuo, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis. International journal of molecular sciences 24 (12) (2023)
Harshita Nivrutti Khedkar, Lung-Ching Chen, Yu-Cheng Kuo, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis. International journal of molecular sciences 24 (12) (2023)
Harshita Nivrutti Khedkar, Lung-Ching Chen, Yu-Cheng Kuo, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis. International journal of molecular sciences 24 (12) (2023)
Ntlotlang Mokgautsi, Yu-Chi Wang, Bashir Lawal, Harshita Nivrutti Khedkar, Maryam Rachmawati Sumitra, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of CCND1/CDK4/PLK1/CD44 in Cancer Types. Cancers 13 (11) (2021)
Harshita Nivrutti Khedkar, Yu-Chi Wang, Vijesh Kumar Yadav, Prateeti Srivastava, Bashir Lawal, Ntlotlang Mokgautsi, Maryam Rachmawati Sumitra, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1. International journal of molecular sciences 22 (11) (2021)